Literature DB >> 10586973

Activation of adenylate cyclase results in down-regulation of c-jun mRNA expression in rat C6 glioma cells.

J K Lee1, M R Choi, D K Song, S O Huh, Y H Kim, H W Suh.   

Abstract

To investigate the possible mechanisms involved in forskolin-induced c-jun mRNA decrease in rat C6 glioma cells, we examined effects of a PKA inhibitor (H-89), a L-type Ca2+ channel blocker (nimodipine), a calmodulin activation inhibitor (calmidazolium chloride) and a Ca2+/calmodulin-dependent protein kinase II inhibitor (KN-62) on forskolin-induced c-jun mRNA down-regulation. H-89 caused a reversal of forskolin-induced c-jun mRNA decrease. Furthermore, nimodipine, KN-62 and calmidazolium chloride partially blocked forskolin-induced c-jun mRNA down-regulation. Our results suggest that activation of adenylate cyclase appears to be involved in a down-regulation of c-jun mRNA expression through a PKA pathway. In addition, L-type calcium channels, calmodulin and Ca2+/calmodulin-dependent protein kinase II may be partially involved in c-jun mRNA down-regulation induced by forskolin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586973     DOI: 10.1016/s0304-3940(99)00780-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.

Authors:  Muhammad Bilal Ahmed; Abdullah A A Alghamdi; Salman Ul Islam; Joon-Seok Lee; Young-Sup Lee
Journal:  Cells       Date:  2022-06-24       Impact factor: 7.666

2.  Protein Kinase A Distribution Differentiates Human Glioblastoma from Brain Tissue.

Authors:  Carla Mucignat-Caretta; Luca Denaro; Domenico D'Avella; Antonio Caretta
Journal:  Cancers (Basel)       Date:  2017-12-21       Impact factor: 6.639

3.  Protein kinase a in cancer.

Authors:  Antonio Caretta; Carla Mucignat-Caretta
Journal:  Cancers (Basel)       Date:  2011-02-28       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.